Immunovia AB (publ) (IMMVF PINK) stock market data APIs
$0.0743
0(0%)
as of May 30, 2025
Try our APIs with
free plan!
Immunovia AB (publ) Financial Data Overview
Immunovia AB (publ), a diagnostic company, develops blood diagnostic for detecting pancreatic cancer in Sweden. It focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Prev. Close
0.0743
Open
0.0743
High
0.0743
Low
0.0743
52 wk Range
0.0738-0.15
Market Cap
918 M
Shares Outstanding
306 M
Revenue
914 K
EPS
-0.0224
Beta
2.688
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Immunovia AB (publ) data using free add-ons & libraries
Get Immunovia AB (publ) Fundamental Data
Immunovia AB (publ) Fundamental data includes:
- Net Revenue: 914 K
- EBITDA: -92 885 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-14
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Immunovia AB (publ) News
New
Change in number of shares and votes in Immunovia AB (publ)
LUND, Sweden, May 31, 2023 /PRNewswire/ -- The number of shares and votes in Immunovia AB (publ) ("Immunovia") have changed as a result of new shares being issued in the rights issue resolved by the b...
Bulletin from the Annual General Meeting in Immunovia AB
LUND, Sweden, May 26, 2023 /PRNewswire/ -- On 26th May 2023, an Annual General Meeting (AGM) was held in Immunovia AB (publ), 556730-4299 at The Spark, Scheeletorget 1, Medicon Village, in Lund. Below...
Immunovia Publishes Interim Report for January-March 2023
LUND, Sweden, May 23, 2023 /PRNewswire/ -- January-March 2023 Net sales amounted to kSEK 520 (182) divided by sales of tests kSEK 379 (122) and royalties kSEK 141(60). Net earnings were MSEK -51.7 (...
Changes to the Nomination Committee's proposal to the Annual General Meeting 2023 in Immunovia AB (publ)
LUND, Sweden, May 22, 2023 /PRNewswire/ -- Immunovia AB (publ) ("Immunovia") published the notice to the Annual General Meeting 2023 on 25 April 2023 together with the Nomination Committee's motivated...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
